Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiepileptic drug development program.

R J Porter

    Progress in Clinical and Biological Research
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    The National Institute of Neurological and Communicative Disorders and Stroke

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Consensus on Subdomains and Measures of Relevance to Affective and Social Cognition Research on Bipolar Disorder (CAS-BD); Outcomes and Recommendations From an International Society for Bipolar Disorders Targeting Cognition Taskforce Study.

    Bipolar disorders·2026
    Same author

    An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma.

    ESMO open·2024
    Same author

    The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.

    The Journal of hospital infection·2024
    Same author

    Electroconvulsive therapy for catatonia secondary to neuroleptic malignant syndrome in a patient with multiple sclerosis.

    The Australian and New Zealand journal of psychiatry·2019
    Same author

    Clinical characteristics associated with the discrepancy between subjective and objective cognitive impairment in depression.

    Journal of affective disorders·2019
    Same author

    Assessing and addressing cognitive impairment in bipolar disorder: the International Society for Bipolar Disorders Targeting Cognition Task Force recommendations for clinicians.

    Bipolar disorders·2018
    Same journal

    DNA homology and chromosome stability: a sensitive yeast genetic system for identifying double-stranded DNA damage.

    Progress in clinical and biological research·2018
    Same journal

    Endotoxin and sepsis: molecular mechanisms of pathogenesis, host resistance, and therapy. Proceedings of the 4th Conference of the International Endotoxin Society. Nagoya, Japan, October 23-27, 1996.

    Progress in clinical and biological research·1998
    Same journal

    The pathogenic role of LBP in gram-negative sepsis and septic shock.

    Progress in clinical and biological research·1998
    Same journal

    The role of interleukin 6 in endotoxin-induced inflammatory responses.

    Progress in clinical and biological research·1998
    Same journal

    Role of nitric oxide and reactive oxygen species in endotoxin shock.

    Progress in clinical and biological research·1998
    Same journal

    Interaction of lipopolysaccharide with a mammalian lyso-phosphatidate acyltransferase (LPAAT) transfected into E. coli, and effect of lisofylline on LPAAT transfected into mammalian cells.

    Progress in clinical and biological research·1998
    See all related articles

    Area of Science:

    • Neurology
    • Pharmacology
    • Drug Development

    Background:

    • The need for novel antiepileptic drugs (AEDs) with improved efficacy and reduced toxicity is critical.
    • Existing AEDs present challenges in terms of effectiveness and side effect profiles.
    • Advancements in neuroscience necessitate the development of next-generation epilepsy treatments.

    Purpose of the Study:

    • To outline the Epilepsy Branch's strategy for developing new antiepileptic drugs.
    • To highlight the collaborative efforts with pharmaceutical companies in drug discovery.
    • To emphasize the importance of objective clinical trial data in epilepsy research.

    Main Methods:

    • The Anticonvulsant Drug Discovery (ADD) Program screens numerous compounds for anticonvulsant properties.

    Related Experiment Videos

  • Preclinical testing utilizes established animal models of epilepsy.
  • Clinical trials are sponsored for promising drug candidates.
  • Investigative techniques developed since the late 1960s are employed for data collection.

    • Main Results:

    • The ADD Program actively identifies and advances potential new AEDs.
    • Collaborations facilitate the progression of drug candidates through the development pipeline.
    • Objective documentation of seizure type and frequency enhances clinical trial validity.

    Conclusions:

    • The Epilepsy Branch's program is instrumental in the search for better epilepsy treatments.
    • Cooperation with pharmaceutical partners accelerates the development of novel AEDs.
    • Rigorous methodology ensures the reliability of data supporting new drug development for epilepsy.